Clomid

Clomid functions by competitively binding to estrogen receptors in the hypothalamus and pituitary gland. This blockage increases Gonadotropin-Releasing Hormone (GnRH) release, subsequently elevating Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH). Increased LH stimulates Leydig cells to produce testosterone. It does not directly affect aromatase activity; instead, it modulates estrogen's effects at the receptor level. This mechanism is key for its use in PCT protocols.

Clomid is most commonly researched for its role in post-cycle therapy (PCT) after cycles involving compounds like Testosterone enanthate (Sustanon 250, Testcort), Oxandrolone (Anavar, Oxane), and HGH (Genexine, NutraGen). Users report using it to mitigate estrogenic side effects such as gynecomastia and water retention. Athletes typically run Clomid during PCT to help restore natural testosterone levels and libido suppressed by anabolic steroids. While not directly used for bulking or cutting phases, its impact on hormonal balance can indirectly support these goals through optimized recovery.

For PCT purposes, athletes typically run Clomid at 50-150mg per day for a duration of 4-6 weeks. A common protocol involves starting with 150mg daily for the first two weeks, followed by a taper down to 50mg daily for the remaining period. Some users report success with lower dosages (25mg/day) over extended cycles (8–12 weeks), but this is less frequently observed. Bloodwork monitoring of testosterone and estrogen levels is highly recommended throughout the cycle to assess effectiveness and adjust dosage as needed.

Commonly reported side effects include mood swings, visual disturbances (blurred vision), headaches, and increased estrogenic activity in some individuals. Users should be at least 21 years of age before considering Clomid use. Due to its estrogen-modulating properties, a Post Cycle Therapy (PCT) plan incorporating aromatase inhibitors may be necessary for some users. Regular bloodwork is crucial to monitor liver function and hormone levels. Hepatotoxicity has been reported; therefore, caution should be exercised with prolonged or high-dose usage.

Mechanism of action

Clomifene citrate competitively binds to estrogen receptors in the hypothalamus, stimulating GnRH release which increases LH and FSH production, ultimately promoting endogenous testosterone synthesis.